Basics ALX Oncology Holdings Inc. IPO Date: July 17, 2020 Sector: Healthcare Industry: Biotech Market Cap: $65.33M Activated in VL: True Average Daily Range Avg Daily Range: $0.85 | 4.06% Avg Daily Range (30 D): $0.06 | 7.88% Avg Daily Range (90 D): $0.04 | 5.77% Institutional Daily Volume Avg Daily Volume: .44M Avg Daily Volume (30 D): 1.09M Avg Daily Volume (90 D): .6M Trade Size Avg Trade Size (Sh.): 103 Avg Trade Size (Sh.) (30 D): 393 Avg Trade Size (Sh.) (90 D): 332 Institutional Trades Total Inst.Trades: 825 Avg Inst. Trade: $1.83M Avg Inst. Trade (30 D): $1.28M Avg Inst. Trade (90 D): $1.28M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.96M Avg Closing Trade (30 D): $1.28M Avg Closing Trade (90 D): $1.28M Avg Closing Volume: 82.83K     News Aug 11, 2025 @ 5:00 PM Gastric Cancer Market on Growth Trajectory: Novel ... Source: Delveinsight May 13, 2025 @ 12:00 PM ALX Oncology to Host R&D Webcast Event Highlightin... Source: N/A Mar 8, 2025 @ 12:33 PM Why the Global Cancer Market Could Surpass $900 Bi... Source: Prnewswire Dec 18, 2024 @ 1:00 PM ALX Oncology to Present Updated Results from Phase... Source: Alx Oncology Nov 1, 2024 @ 9:30 PM ALX Oncology Announces Results from Phase 1b/2 Tri... Source: Alx Oncology Financials   TTM Q2 2025 Q1 2025 Basic EPS $-2.16 $-.49 $-.58 Diluted EPS $-2.16 $-.49 $-.58 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -116.57M $ -25.95M $ -30.75M Operating Income / Loss $ -121.65M $ -26.65M $ -31.82M Cost of Revenue $ $ $ Net Cash Flow $ 3.77M $ -1.31M $ 3.05M PE Ratio